TrialAnnals of the rheumatic diseases2023

Rituximab versus azathioprine for maintenance of remission for patients with ANCA-associated vasculitis and relapsing disease: an international randomised controlled trial.

Rona M Smith et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.